1.
Oliveira DHF de, Amador AE, Oliveira CA de, et al. SEMAGLUTIDE AND TIRZEPATIDE IN THE TREATMENT OF OBESITY: BENEFITS, RISKS, AND CLINICAL PERSPECTIVES OF GLP-1 RECEPTOR AGONISTS. REASE. 2026;12(6):1-17. doi:10.51891/rease.v12i6.28619